Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients
NCT05401149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3058
Last updated 2024-10-17
Summary
The objective of this study is to find out if Chinese Acute Ischaemic Stroke (AIS) patients older than 80 years benefit from intravenous (IV) Recombinant Tissue Plasminogen Activator (rt-PA) treatment within 4.5 hours of symptom onset in a real-world clinical setting.
Conditions
Interventions
- DRUG
-
rt-PA
Recombinant Tissue Plasminogen Activator
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-18
- Primary Completion
- 2022-12-14
- Completion
- 2022-12-14
Countries
- China
Study Locations
More Related Trials
-
EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
NCT05429476 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
NCT04915729 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
NCT02854592 ·Status: COMPLETED
-
Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
NCT05856851 ·Status: RECRUITING ·Phase: PHASE3
-
An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
NCT02229890 ·Status: COMPLETED
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）
NCT05281549 ·Status: UNKNOWN ·Phase: PHASE2
-
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
NCT03661411 ·Status: COMPLETED ·Phase: PHASE4
-
Rt-PA in the Treatment of Acute Ischemic Stroke
NCT00153036 ·Status: COMPLETED ·Phase: PHASE3
-
Tenecteplase Thrombolytic Therapy for Acute Ischemic Stroke in China
NCT06078995 ·Status: RECRUITING
-
Argatroban Plus R-tPA for Acute Ischemic Stroke
NCT03740958 ·Status: COMPLETED ·Phase: PHASE4
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
NCT02452502 ·Status: COMPLETED ·Phase: NA
-
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
NCT02016547 ·Status: TERMINATED ·Phase: PHASE4
-
Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
NCT05631847 ·Status: COMPLETED ·Phase: NA
-
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
NCT03541668 ·Status: COMPLETED ·Phase: PHASE3
-
Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
NCT05745259 ·Status: UNKNOWN ·Phase: PHASE3
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
NCT00044057 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke
NCT05515393 ·Status: UNKNOWN ·Phase: PHASE2
-
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
NCT00840671 ·Status: COMPLETED ·Phase: PHASE3
-
Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
NCT04733742 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
NCT04504864 ·Status: UNKNOWN ·Phase: PHASE4